Takeda to present phase 3 cancer drug data at ESMO 2026
Tweet Send to a Friend
Takeda Pharmaceutical (TSE: 4502 / NYSE: TAK) will present new oncology pipeline data at the European Society for Medical Oncology ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


